DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Prins MH, Lensing AWA, Brighton TA. , et al.
Oral rivaroxaban versus enoxaparin with vitamin K antagonist for the treatment of symptomatic venous thromboembolism in patients with cancer (EINSTEIN-DVT and EINSTEIN-PE): a pooled subgroup analysis of two randomised controlled trials.
Lancet Haematol 2014;
1 (01) e37-e46
We do not assume any responsibility for the contents of the web pages of other providers.